# Atossa Therapeutics, Inc.: Form 8-K, filed Feb 11, 2026

- Company: [Atossa Therapeutics, Inc.](/companies/atos.md) (CIK 1488039)
- Form: 8-K
- Filed: 2026-02-11
- Accepted by EDGAR: Feb 11, 2026, 08:45 ET
- Period: 2026-02-11
- Accession: 0001193125-26-045628
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1488039/000119312526045628/atos-20260211.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1488039/000119312526045628/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1488039/000119312526045628/atos-20260211.htm

Filed Feb 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-045628. Last ingested by Listed: Nov 10, 2026, 17:09 ET. No prices; not investment advice.
